Eurofins: Q1 sales up 7%

(CercleFinance.com) - Eurofins Scientific has published Q1 2020 sales of 1,142 million euros, up 7% as reported and up 4.
1% in organic terms, reflecting the strong resilience of both the group and its end markets.

The bio-analysis service provider says "Eurofins scientists develop multiple new solutions to support the world's fight against the COVID-19 pandemic - ramping up production to enable over 20 million patients tests per month by end May 2020".

While it says that "at this point in time, it is difficult to predict the impact of the COVID-19 pandemic on the remainder of the year," nevertheless, "Eurofins is mostly positioned in highly resilient markets with a large and globally diversified network of laboratories active in essential sectors".

The market doesn't seem to be convinced, however - the share is down over 1.5% in early trading on Tuesday.


Copyright (c) 2020 CercleFinance.com. All rights reserved.